Advanced Filter

Filter by Group

Filter by Market Availability

Afatinib is a tyrosine kinase inhibitor which is a 4-anilinoquinazoline. It is prepared has the dimaleate salt. FDA approved on July 12, 2013.
Matched Name: … Afatinib
Matched Description: … Afatinib is a tyrosine kinase inhibitor which is a 4-anilinoquinazoline. It is prepared has the dimaleate …
Matched Salts name: … Afatinib dimaleate …
Matched Categories: … afatinib
Displaying 1 drug